Literature DB >> 32476830

CA 15.3: a marker of disease activity in sarcoidosis.

Yasemin Türk1, Clara Shapiro1, Gert-Jan Braunstahl1.   

Abstract

Entities:  

Year:  2017        PMID： 32476830      PMCID： PMC7170116          DOI： 10.36141/svdld.v34i1.4786

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN： 1124-0490            Impact factor:   0.670


× No keyword cloud information.
  4 in total

1.  Transient elevation of the tumor markers CA 15-3 and CASA as markers of interstitial lung disease rather than underlying malignancy in dermatomyositis sine myositis.

Authors:  Richard C W Wong; Scott Brown; Belinda E Clarke; Sandra Klingberg; Paul V Zimmerman
Journal:  J Clin Rheumatol       Date:  2002-08       Impact factor: 3.517

2.  Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.

Authors:  R Colomer; A Ruibal; J Genollá; D Rubio; J M Del Campo; R Bodi; L Salvador
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

3.  CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases.

Authors:  A Kruit; W B M Gerritsen; N Pot; J C Grutters; J M M van den Bosch; H J T Ruven
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2010-07       Impact factor: 0.670

4.  Serum CA 15-3 is increased in pulmonary fibrosis.

Authors:  A Ricci; S Mariotta; E Bronzetti; P Bruno; L Vismara; C De Dominicis; B Laganà; G Paone; M Mura; P Rogliani; M Mastrangeldo; S Sciacchitano; Cesare Saltini
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670
  4 in total
  1 in total

1.  Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy.

Authors:  Yan Zhang; Jing Zhao; Yajun Wang; Wei Cai; Xiaoli Zhang; Kaifu Li; Wenqing Liu; Ye Zhao; Hua Kang
Journal:  Dis Markers       Date:  2022-05-19       Impact factor: 3.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.